A New York Times exposé alleges that Elon Musk, CEO of SpaceX, received advance notice of drug tests required by the company's federal contractor status.
Sources claim this allowed Musk to circumvent the random testing process, despite his admitted use of substances like ketamine, ecstasy, and psilocybin mushrooms.
The report suggests Musk's substance use increased during his involvement in Donald Trump's presidential campaign, with claims of bladder issues from frequent ketamine use and a daily medication box containing numerous pills, some resembling Adderall.
While Musk claims a prescription for ketamine to treat depression, the extent of his alleged use raises concerns about exceeding recommended dosages.
Standard drug tests often don't screen for ketamine, making advance notice even more advantageous. The allegations raise questions about fairness and accountability within SpaceX.